期刊文献+

515例妇女高危型HPV感染检测结果分析 被引量:12

Case Study of 515 Women with High-risk Human Papillomavirus Infection
下载PDF
导出
摘要 目的:了解高危型人乳头瘤病毒(HPV)在妇女中的感染情况方法:将健康体检妇女以年龄40岁为界分为2个实验组:低年龄组(<40岁)和高年龄组(≥40岁),应用高危型人乳头瘤病毒多重核酸扩增荧光定量检测技术对5 1 5例健康体检妇女进行高危型HPV感染检测,比较低年龄组和高年龄组之间高危型HPV感染情况,对结果进行统计学分析。结果:515例健康体检妇女中,高危型HPV感染总阳性率为8.54%(44/515),低年龄组和高年龄组高危型HPV感染率分别为3.45%(3/87)和9.58%(41/428),高年龄组高危型HPV感染阳性率高于低年龄组(P<0.05),高危型HPV感染阳性率在40岁以上妇女感染率较高结论:40岁以上妇女为高危型HPV感染高发人群,加强高危型HPV检测对降低该人群宫颈癌的发生率和致死率至关重要。 Objective: To investigate the infection status of high-risk human papillomavirus ( HPV ) in women. Methods: The study group consisting of 515 healthy women was divided into two experimental groups. One was the low-age group ( 〈40 years old ), and the other was the high-age group ( ≥40 years old ). The infection status of high-risk HPV was determined by the multiplex polymerase chain reaction fluorescence detection technology. The results of the two groups were compared and statistically analyzed, Results: The total high-risk HPV-positive rate for the entire study group was 8.54% ( 44/515 ). The positive rate was 3.45% ( 3/87 ) for the low-age group, and 9.58% ( 41/428 ) for the high age group ( P〈 0.05 ). Conclusion: Women over 40 years old have a high risk for high-risk HPV infection. High-risk HPV detection methods must be enhanced to decrease the incidence and mortality of cervical cancer in women over 40 years old.
作者 李世霞
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2011年第16期954-956,共3页 Chinese Journal of Clinical Oncology
关键词 人乳头瘤病毒 荧光定量PCR 感染 年龄 Human papillomavirus Fluorescent quantitation PCR Infection Age
  • 相关文献

参考文献8

  • 1Salih MM, Sail ME, Hart K, et al. Genotypes of human papilloma virus in Sudanese women with cervical pathology[J]. Infect Agent Cancer, 2010, 5: 26.
  • 2Hedau S, Kumar U, Hussain S, et al. Breast cancer and human papillomavirus infection: no evidence of HPV etiology of breast cancer in Indian women[J]. BMC Cancer, 2011, 11: 27.
  • 3Zhang D, Zhang Q Zhou L, et al. Comparison of prevalence, viral load, physical stares and expression of human papillomavirus-16,-18 and--58 in esophageal and cervical cancer: case--control study[J]. BMC Cancer, 2010, 10: 650.
  • 4陈玲,杨兰,孙振柱,张海洋,任涛,田秀云,庞丽娟,常彬,李洪安,李锋.新疆哈萨克族食管鳞癌中人乳头状瘤病毒感染的检测[J].中国肿瘤临床,2008,35(8):445-447. 被引量:8
  • 5Oliveira-Silva M, Lordello CX, Zardo LM, et al. Human Papillomavirus in Brazilian women with and without cervical lesions[J]. VirolJ, 2011, 8: 4.
  • 6Swangvaree SS, Kongkaew P, Rugsuj P, et al. Prevalence of high-risk human papillomavirus infection and ctologic rsults in Thailand[J].Asian PacJ Cancer Prey, 2010, 11 (6): 1465-1468.
  • 7Colon-Lopez V, Ortiz AP, PalefskyJ. Burden of human papillomavirus infection and related comorbidities in men: implications for research, disease prevention and health promotion among Hispanic men[J]. P R Health SdJ, 2010, 29(3): 232-240.
  • 8Ramamoorthy S, Liu YT, Luo L, et al. Detection of multiple human papillomavirus genotypes in anal carcinoma[J]. Infect Agent Cancer, 2010, 5: 17.

二级参考文献9

  • 1van den Brule AJ, Meijer CJ, Bakels V, et al. Rapid detection of human papillomavirus in cervical scrapes by combined general primer-mediated and type-specific polymerase chain reaction[J].J Clin Microbiol, 1990, 28(12): 2739-2743
  • 2de Roda Husman AM, Walboomers JM, van den Brule AJ, et al. The use of general primers GP5 and GP6 elongated at their 3' ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR [J].J Gen Virol.1995, 76 (Pt 4): 1057-1062
  • 3Daly JM, Fry WA, Little AG, et al. Esophageal cancer: results of an American College of Surgeons Patient Care Evaluation Study [J].J Am Coll Surg, 2000, 190(5): 562-572
  • 4Pisani P, Parkin DM, Bray F, et al. Estimates of the worldwide mortality from 25 cancers in 1990 [J]. IntJ Cancer, 1999, 83(1): 18-29
  • 5Zur Hausen H. Cervical carcinoma and human papillomavirus: on the road to preventing a major human cancer[J]. J Natl Cancer Inst, 2001, 93(4): 252-253
  • 6Munoz N, Bosch FX, de Sanjose S, et al. Epidemiologic dassification of human papillomavirus types associated with cervical cancer[J]. N Engl J Med, 2003, 348(6): 518-527
  • 7Nagai Y, Maehama T, Asato T, et al. Detection of human papillomavirus DNA in primary and metastatic lesions of carcinoma of the cervix in women from Okinawa, Japan[J]. Am J Clin Oncol, 2001, 24(2): 160-166
  • 8Suzuk L, Noffsinger A, Hui YZ, et al. Detection of human papillomavirus in esophageal squamous cell carcinoma[J]. Cancer, 1996, 78(4): 704-710
  • 9Berkhout RJ, Tieben LM, Smits HL, et al. Nested PCR approach for detection and typing of epidermodysplasia verruciformis-associated human papillomavirus types in cutaneous cancers from renal transplant recipients[J].J Clin Microbiol. 1995, 33 (3): 690 - 695

共引文献7

同被引文献96

  • 1李瑞珍,石菊芳,周庆芝,吴瑞芳,李霓,乌兰娜,周艳秋,王倩,刘志红,刘彬,乔友林.应用基因芯片技术检测高危型人乳头瘤病毒在宫颈癌筛查中的评价[J].中华医学杂志,2006,86(5):307-311. 被引量:52
  • 2古扎丽努尔.阿不力孜,程静新,米克热木,古兰丹,李华,米合日尼沙,米日古丽,米日古丽.艾乃土,路玲.新疆维吾尔族妇女宫颈癌的HPV谱研究[J].肿瘤,2007,27(5):379-382. 被引量:48
  • 3王海波,谢勇,郭洁.通用引物PCR法在人乳头瘤病毒基因检测中的应用[J].海南医学,2007,18(8):49-51. 被引量:2
  • 4中国癌症基金会译.世界卫生组织.子宫颈癌综合防治基本实践指南[M].北京:北京大学医学出版社,2008:167.
  • 5Hedau S,Kumar U, Hussain S, et al. Breast cancer and human papillomavirus infectionno evidence of HPV e- tiology of breast cancer in Indian women F J]. BMC Cancer, ,2011,11 (1) : 27.
  • 6Szostek S, Klimek M, Zawilinska B, et al. Genotype- specific human papilfomavirus detection in cervical smears[J]. Aeta Bioehim Pol, 2008,55 (4) 1-6.
  • 7Jemal A, Bray F, Center M_M, et al. Global cancer statistics[J]. CA CancerJ Clin, 2011, 61(2) :69-90.
  • 8Donders GG, Bellen G, Dederq A, et al. Change in knowledge of women about cervix cancer, human papilloma virus (HPV) and HPV vaccination due to introduction of HPV vaccines[J]. EurJ Ob- stet Gynecol Reprod Biol, 2009, 145(1):93-95.
  • 9Song SH, Lee JK, Seok OS, et al. The relationship between cyto- kines and HPV-16, HPV-16 E6, E7, and high-risk HPV viral load in the uterine cervix[J]. Gynecol Oncol, 2007, 104(3):732-738.
  • 10Salimovic-Besic I. Evaluation of hybrid capture 2 HPV DNA test and two variants of polymerase chain reaction (PCR-PGMYll/ PGMY09 and PCR-CPI/CPIIG) according to HPV types[J]. Med Arh, 2007, 61(3):135-137.

引证文献12

二级引证文献73

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部